Publications

2020
Working Paper

What Can Economics Say About Alzheimer's Disease?

By: Amitabh Chandra, Courtney Coile and Corina Mommaerts

Alzheimer’s Disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the... View Details

Keywords: Health Disorders; Health Care and Treatment; Economics

March 2025
Supplement

Intuition Robotics: An AI Companion for Older Adults (B)

By: Amit Goldenberg, Elie Ofek and Orna Dan

Two years after Intuition Robotics opted to pursue a business-to-government contract with the New York State Office of the Aging, and put direct-to-consumer efforts on the back burner, it was at a crossroads. The partnership had been successful, and the company had... View Details

Keywords: Business Model; AI and Machine Learning; Resource Allocation; Business and Government Relations; Partners and Partnerships; Business Strategy; Health Industry; Health Industry; New York (state, US); United States

Research Summary

Evolution of the Global Beauty Industry

By: Geoffrey G. Jones

This research examines the global beauty industry, which includes cosmetics, deodorants, fragrances, hair care, oral hygiene and skin care. Today global sales of cosmetics and toiletries are in excess of U.S. $380 billion. This research examines the growth of this... View Details

March 2014 (Revised November 2020)
Case

The Novartis Malaria Initiative

By: Michael Chu, Vincent Marie Dessain and Emilie Billaud

The Novartis Malaria Initiative was designed, as a result of a precedent–setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria—"at no profit"—for public health systems. What had begun as an exemplary act of... View Details

Keywords: Health Care and Treatment; Product Marketing; Corporate Social Responsibility and Impact; Social Enterprise; Pharmaceutical Industry; Switzerland; Africa; Nigeria

2020
Discussion Paper

Acting Now While Preparing for Tomorrow: Competitiveness Upgrading Under the Shadow of COVID-19

By: Christian H.M. Ketels and Peter Clinch

This paper aims to provide policy makers, especially those focused on the longer-term growth potential of their countries, with an initial framework to think about their action priorities in the context of the overall COVID-19 response. Our focus is on the... View Details

Keywords: Competitiveness; COVID-19 Pandemic; Competition; Government Administration; Health Pandemics; Economy; Supply Chain; Safety

Research Summary

Personal Data in Marketing

By: John A. Deighton

Between 10% and 20% of all marketing activity in the United States, and a smaller proportion internationally, relies on data about individuals, whether personally identifying or pseudonomized. These data flow across a system of established and emerging firms operating... View Details

Keywords: Data; Personal Data; Information Technology; Industry Structure; Marketing

June 2010
Article

Leadership Competencies for Implementing Planned Organizational Change

By: Julie Battilana, Mattia Gilmartin, Anne-Claire Pache, Metin Sengul and Jeffrey A. Alexander

This paper bridges the leadership and organizational change literatures by exploring the relationship between managers' leadership competencies (namely, their effectiveness at person-oriented and task-oriented behaviors) and the likelihood that they will emphasize the... View Details

Keywords: Leadership; Competency and Skills; Organizational Change and Adaptation; Planning; Relationships; Business Processes; Projects; Theory; Change; Behavior; Health Industry; United Kingdom

Find at Harvard

08 May 2023
Research & Ideas

How Trump’s Anti-Immigrant Rhetoric Crushed Crowdfunding for Minority Entrepreneurs

but that gap triples during periods of high public anxiety over immigration in the United States. “When there is the greatest anxiety, we see this funding shortfall.” Banks have historically rejected loan applications from Black, Asian,... View Details

Keywords: by Scott Van Voorhis

Teaching Interest

Managing Global Health: Applying Behavioral Economics to Create Impact (MBA)

Health, and development more broadly, is not something we give to people: it is something they produce themselves, interacting with supply-side and institutional factors. This course trains students to see through the lens of the end-user and to use the levers of... View Details

2010
Working Paper

Conceptual Foundations of the Balanced Scorecard

By: Robert S. Kaplan

David Norton and I introduced the Balanced Scorecard in a 1992 Harvard Business Review article (Kaplan & Norton, 1992). The article was based on a multi-company research project to study performance measurement in companies whose intangible assets played a central role... View Details

Keywords: Asset Management; Balanced Scorecard; Management Systems; Performance Improvement; Strategy

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry

Find at Harvard

September 2023 (Revised September 2023)
Teaching Note

Roche: Innovation and Access to Healthcare

By: George Serafeim

Teaching Note for HBS Case No. 123-075. In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to... View Details

Keywords: ESG; Access To Care; Healthcare; Healthcare Access; Innovation; Social Impact; Affordable; Health Care and Treatment; Innovation and Invention; Product Development; Resource Allocation; Corporate Social Responsibility and Impact; Health Industry

07 May 2013
First Look

First Look: May 7

Publications 2006 Review of Financial Studies Unstable Equity: Combining Banking with Private Equity Investing By: Fang, Lily H., Victoria Ivashina, and Josh Lerner Abstract—Bank-affiliated private equity groups account for 30% of all... View Details

Keywords: Carmen Nobel

December 1994 (Revised March 1996)
Case

Ciba Consumer Pharmaceuticals' Acutrim: Challenges and Opportunities in Today's Diet Industry

By: Nancy F. Koehn and Rebecca Voorheis

Since its introduction in 1983, Acutrim has been a major player in the U.S. appetite suppressant market and in the broader diet industry. This case focuses on the strategic, regulatory, marketing, and financial challenges this product and the rapidly changing diet... View Details

Keywords: Product Marketing; Market Design; Industry Structures; Public Ownership; Problems and Challenges; Opportunities; Food and Beverage Industry; Pharmaceutical Industry; United States

05 Dec 2017
Research & Ideas

What We've Learned from 101 Entrepreneurs in Emerging Markets

Harvard Business School’s exploration of the evolution of business leadership in Africa, Asia, and Latin America has reached an important milestone. This month the Creating Emerging Markets project will publish interviews 100 and 101... View Details

Keywords: by Sean Silverthorne

February 2022 (Revised November 2022)
Case

Nuritas

By: Mitchell Weiss, Satish Tadikonda, Vincent Dessain and Emer Moloney

Nora Khaldi had built a technology “to unlock the power of nature” in the service of extending human lifespan and improving health, and now in April 2020 was debating telling her Board of Directors she wanted to put on ice some of her discoveries. Nuritas, the company... View Details

Keywords: Cash Burn; Cash Flow Analysis; Pharmaceutical Companies; Founder; Artificial Intelligence; AI; Entrepreneurship; Health Testing and Trials; Health Care and Treatment; Decision Making; Market Entry and Exit; AI and Machine Learning; Pharmaceutical Industry

January 2018
Article

The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials

By: Aaron V. Kaplan and Ariel D. Stern

The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details

Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States

Find at Harvard

July 2016 (Revised January 2017)
Case

Banking on Change: Aligning Culture and Compensation at Morgan Stanley

By: Malcolm S. Salter

This case study was prepared as part of a research project on Culture, Conduct, and Governance in Financial Firms. The objective of this project is to compare and contrast the efforts of U.S. and European banks to induce changes in organization culture in the aftermath... View Details

Keywords: Business or Company Management; Corporate Accountability; Ethics; Organizational Culture; Corporate Governance; Banks and Banking; United States; Europe